Various tissue-based predictive biomarkers have been proposed, such as microsatellite instability (MSI)5,6, tumor mutational burden (TMB)7, programmed death-ligand 1 (PD-L1) expression8, and tumor-infiltrating lymphocyte (TIL) count9. The gene discussed is CD274; the disease is neoplasm.